Milan Criteria for Liver Transplantation
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۲۰ • واحد: cm
حداقل ۰ — حداکثر ۲۰ • واحد: cm
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Meets Criteria0–0
- Does Not Meet Criteria1–1
The Milan Criteria for Liver Transplantation calculator is designed for bedside assessing suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines in clinical practice. The resulting score directly guides clinician decision-making regarding timing emergent endoscopy, initiating high-dose proton.
Clinical Guidelines & Evidence
Assesses suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines
Clinical Indication
The Milan Criteria for Liver Transplantation is indicated for bedside clinical practice to support Assesses suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Count all viable tumors (exclude completely necrotic lesions after treatment).
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Count all viable tumors (exclude completely necrotic lesions after treatment).
Milan Criteria: (1 tumor ≤5 cm) OR (2-3 tumors, each ≤3 cm) AND no extrahepatic disease AND no major vessel involvement
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| tumor_count | string | Yes | Number of HCC tumors identified on imaging |
| single_tumor_size | float | No | Size of single tumor in cm (only if single tumor)(cm) |
| largest_tumor_size | float | No | Size of largest tumor in cm (only if 2-3 tumors)(cm) |
| extrahepatic_involvement | string | Yes | Evidence of extrahepatic disease (metastases) |
| major_vessel_involvement | string | Yes | Major vascular invasion (portal vein or hepatic vein thrombosis) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Meets Criteria | Eligible for liver transplantation |
| 1–1 | Does Not Meet Criteria | Not eligible for liver transplantation |
Evidence-Based References (EBM)
- Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693-9. doi: 10.1056/NEJM199603143341104.DOI: 10.1056/NEJM199603143341104
- Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5.DOI: 10.1016/S1470-2045(08)70284-5
- Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011 Oct;17 Suppl 2:S44-57. doi: 10.1002/lt.22365.DOI: 10.1002/lt.22365
- Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.DOI: 10.1002/hep.29913